Pride for donors and passion for patients

What makes Grifols unique is that people, from donors to patients, are at the heart of everything we do.

Thanks to our donors' generosity, we are able to produce plasma-derived medicines that treat and prevent sometimes life-threatening diseases, illnesses, and conditions.

The patients we serve around the world are able to lead better lives thanks to plasma-derived medicines and the donors. Patients drive the work we do every day.

Pride for donors

Our mission is to help improve the health and well-being of people around the world. To do so, we depend on the generosity of dedicated and committed plasma donors.

Plasma contains hundreds of essential proteins and antibodies vital to the body's ability to maintain critical functions.

Voluntary plasma donations make the production of our medicines possible. We are proud of donors - their health and safety is a top priority.

To know how to become a donor visit

A leader in plasma collection

We are the largest collector of human plasma with over 350 plasma donation centers globally that provide Grifols with a dependable supply of the plasma needed to produce our therapies.

Over 10,000,000 donations are made at our centers annually. Plasma collection is performed in highly controlled environments by professionally licensed and trained staff.

Commitment to local communities

Our commitment to plasma donors extends to the communities in which they live. Like small community-based businesses, Grifols plasma donation centers help strengthen cities and towns by creating job opportunities, stimulating the local economy, and offering a variety of outreach activities.

All of our plasma donation centers participate in community engagement events and contribute through charitable donations and volunteer programs. 

Additionally, we maintain a commitment to serve as model employers by providing robust workforce development, educational support, intensive training, and ongoing career opportunities.

Passion for patients

Since we began in 1909, we have been committed to improving the health and well-being of people around the world. Our commitment to patients inspires us to maintain the highest standards of quality and safety for the medications we produce.

Patients who receive our medicines often suffer from rare, chronic, and sometimes life-threatening conditions that require treatment with unique proteins found only in human plasma.

Our medicines are designed for various medical fields:

Hemophilia and von Willebrand disease are genetic diseases that prevent the blood from properly clotting. Hereditary antithrombin III deficiency can lead to an increased risk for the development of abnormal blood clots.

Primary immunodeficiency disease (PIDD) occurs in people born with an immune system that is either absent or impaired. When part of the immune system does not work properly, the body lacks the ability to fight off infection. Rapid immune protection in potentially life-threatening situations, such as suspected exposure to rabies, tetanus, hepatitis A, or hepatitis B, is provided by plasma-derived medicines.

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a rare autoimmune neurological disorder that causes the immune system to attack and damage the protective covering surrounding the nerves. Over time, this leads to weakness, pain, numbness, and tingling in the arms and legs.

Alpha-1-antitrypsin deficiency (alpha-1) is a genetic condition that occurs when a person has lower than normal levels of a protective protein known as alpha-1-antitrypsin, allowing certain enzymes to attack healthy tissue in the lungs. Alpha-1 deficit is the leading cause of genetic chronic obstructive pulmonary disease (COPD).

Albumin, the most abundant protein in human plasma, restores circulating blood volume and protein loss following trauma, shock, or severe burns.